PODCAST

CME

ReachMD

science & medicine medicine

All Episodes

00:00:00

Treatment Revolution in IgA Nephropathy

CME ·

2025/09/24

Faculty: Shikha Wadhwani, MD Faculty: Dana Rizk, MD For the second episode of the KDIGO IgA Nephropathy (IgAN) podcast series, Dr. Dana Rizk and Dr. Shikha Wadhwani discuss the IgAN treatment revolution. The conversation explores how a deeper understanding of the disease's pathophysiology has led to new therapeutic options, moving beyond traditional supportive care. Key topics include: The shift in IgAN treatment since the KDIGO 2021 guidelines a The four-hit hypothesis of

00:00:00

Collaborative Care for CRSwNP Expert and Patient...

CME ·

2025/09/12

Host: Stella Lee, MD Guest: Katie Buchheit, MD Guest: Michael E. Wechsler, MD, MMSc Chronic rhinosinusitis with nasal polyps (CRSwNP) presents a large burden on more than 3 million patients with the conditions — especially when intertwined with asthma and allergy. Join our discussion between patients with CRSwNP and leading experts in ENT, allergy, and pulmonary medicine as they: Breakdown how to recognize key inflammatory patterns. Discuss the burden of illness and goals of

00:00:00

Global Perspectives on Perioperative Immunotherapy in...

CME ·

2025/08/29

Host: Kevin J Harrington, PhD, FRCP, FRCR, FRSB Host: Christophe Le Tourneau, MD, PhD Join our experts as they examine the integration of perioperative immune checkpoint inhibitors (ICIs) in the management of resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC). Drs. Le Tourneau and Harrington discuss unmet needs and limitations of current treatment and review data from trials supporting the use of perioperative ICIs, emphasizing their event-free survival

00:00:00

Chairperson Perspective: Acromegaly Care:...

CME ·

2025/08/15

Host: Maria Fleseriu, MD, FACE Acromegaly, a rare endocrine disorder caused by excessive growth hormone (GH) secretion, has a profound impact on affected individuals and healthcare systems. Patients often experience delays in diagnosis, averaging 4 to 6 years, which exacerbates disease progression and leads to irreversible comorbidities. Do you know how to effectively treat acromegaly to increase your patients’ quality of life? Tune in for an overview of the latest data.

00:00:00

Advanced Therapeutic Strategies and Resistance...

CME ·

2025/08/14

Host: Shankara Paneesha, MD FRCP FRCPath Listen to Dr. Shankara Paneesha and discover the evolving treatment landscape for relapsed CLL. Get insights on BTK resistance, new treatment options including cellular therapy, and the importance of patient-specific factors in treatment decisions.

00:00:00

Breaking New Ground: Acoramidis Reduces AF Events in...

CME ·

2025/08/08

Faculty: Kevin Alexander, MD This brief clinical discussion examines findings presented at the ESC Heart Failure 2025 meeting in Belgrade, Serbia, on the impact of acoramidis in transthyretin amyloid cardiomyopathy (ATTR-CM). The analysis highlights a reduction in atrial fibrillation events and an improvement in cardiovascular outcomes among patients treated with acoramidis, including those with both wild-type and variant transthyretin (TTR). Data from the ATTRibute-CM study are

00:00:00

Community Clinic: Translating Data Into Action ─...

CME ·

2025/07/25

Guest: Robert J. Motzer, MD Guest: Elizabeth R. Plimack, MD, MS, FASCO Our experts, Drs. Robert Motzer and Elizabeth Plimack, discuss first-line treatment strategies for advanced renal cell carcinoma in a community clinic setting. Drawing from pivotal clinical trials and guideline recommendations, they highlight how to personalize therapy based on IMDC risk stratification and patient characteristics. Practical decision-making in both intermediate- and poor-risk disease is examined

00:00:00

TTR Levels and Associated Disease Risk: Insights from...

CME ·

2025/07/24

Faculty: Ahmad Masri, MD, MS Review findings from the UK Biobank presented recently at the Peripheral Nerve Society meeting, revealing that naturally low transthyretin (TTR) levels are associated with a higher prevalence of cardiovascular biomarkers, such as NT-proBNP, and comorbidities, including peripheral arterial disease, stroke, and cognitive decline. The data suggest that low TTR may serve as a marker of broader systemic illness, both in patients with TTR amyloidosis and in the

00:00:00

Optimize Outcomes in CKD & T2D: A Practical Approach...

CME ·

2025/07/22

Guest: Amy Mottl, MD, MPH Guest: Prof. Christoph Wanner The CONFIDENCE trial shows that combining an SGLT2 inhibitor with finerenone cuts albuminuria by more than 50% in patients with chronic kidney disease and type 2 diabetes. In this video, 2 nephrologists discuss how they apply these insights in clinical practice. A compelling real-world case highlights the power of 4-pillar therapy to optimize cardio-renal outcomes. Tune in to see how modern treatment strategies are

00:00:00

New and Emerging PAH Therapies and Approaches: A...

CME ·

2025/07/03

Guest: Vallerie V. McLaughlin, MD Guest: Ioana Preston, MD Guest: Kelly Chin, MD, MSCA Pulmonary arterial hypertension (PAH) is a serious, progressive condition that involves making the correct diagnosis and identifying patient comorbidities as important first steps to creating a successful treatment approach. And while identifying which WHO Group a patient belongs to is key, part of the art of treating PAH is recognizing that many patients can have overlap between groups. Our

00:00:00

PH Management in Unique Patients and Conditions

CME ·

2025/07/03

Guest: Martha Kingman, DNP, FNP-C Guest: Ioana Preston, MD Guest: Jean M. Elwing, MD Pulmonary arterial hypertension (PAH) is a serious, progressive condition and successfully managing patients can present certain challenges. Treatment selection is multifactorial and often involves the consideration of myriad patient factors, including WHO Group, objective risk stratification score, cardiac functioning on imaging, and shared decision-making. And while all patients who are

00:00:00

Impact of Finerenone on eGFR Slope by Baseline...

CME ·

2025/06/07

Guest: Finnian R. McCausland, MD These video briefs feature expert commentary on the latest clinical data presented at ERA 2025 and highlight finerenone’s evolving role in the care of patients with the cardio-kidney-metabolic syndrome. Specialists discuss new findings from the CONFIDENCE trial and FINEARTS-HF trial, including the efficacy and safety of combining finerenone with SGLT2 inhibitors, finerenone’s impact on eGFR slope across albuminuria levels, and the prognostic

00:00:00

The CONFIDENCE Trial: Data Insights

CME ·

2025/06/07

Guest: prof. Hiddo Heerspink These video briefs feature expert commentary on the latest clinical data presented at ERA 2025 and highlight finerenone’s evolving role in the care of patients with the cardio-kidney-metabolic syndrome. Specialists discuss new findings from the CONFIDENCE trial and FINEARTS-HF trial, including the efficacy and safety of combining finerenone with SGLT2 inhibitors, finerenone’s impact on eGFR slope across albuminuria levels, and the prognostic significance of

00:00:00

Albuminuria Change and Finerenone's Effect on CV...

CME ·

2025/06/07

00:00:00

Topline Results of the CONFIDENCE Trial

CME ·

2025/06/07

Guest: Rajiv Agarwal, MBBS, MD, FASN, BRCU These video briefs feature expert commentary on the latest clinical data presented at ERA 2025 and highlight finerenone’s evolving role in the care of patients with the cardio-kidney-metabolic syndrome. Specialists discuss new findings from the CONFIDENCE trial and FINEARTS-HF trial, including the efficacy and safety of combining finerenone with SGLT2 inhibitors, finerenone’s impact on eGFR slope across albuminuria levels, and the prognostic

00:00:00

Optimizing Barostim Outcomes: Practical Approaches to...

CME ·

2025/06/06

Host: Cynthia J. Bither, ACNP-BC, MSN Guest: Andrea Wallace, MSN, FNP-C, HF-Cert Medical devices such as Barostim – or baroreflex activation therapy (BAT) – can play an important role in improving the quality of life and providing symptom relief for patients with heart failure with reduced ejection fraction, or HFrEF. NPs and nurses are key members of the healthcare team who identify patients as potential candidates for this therapy, due in large part to their expertise in

00:00:00

Advancing Care in Non-Clear Cell RCC: Optimizing ICI...

CME ·

2025/05/09

Guest: Pedro Barata, MD, MSc, FACP Guest: Sumanta K. Pal, MD, FASCO Stay at the forefront of nccRCC care by exploring the latest advances in treatment strategies. Gain key insights into optimizing patient selection, enhancing diagnostic accuracy, and managing adverse events to improve patient outcomes. This comprehensive activity delves into emerging data, the rationale for ICI/TKI combination therapy, the latest clinical trial findings, and best practices for treatment sequencing

00:00:00

First Results From Cohort 4 of the SunRISe-1 Trial

CME ·

2025/05/01

This series of video briefs features Dr. Neal Shore reporting from AUA 2025 in Las Vegas. Tune in for timely updates on innovatively delivered intravesical therapies for non–muscle invasive bladder cancer (NMIBC). Dr. Shore presents key findings from the SunRISe-1 trial, highlighting 1-year durability and patient-reported outcomes data in BCG-unresponsive high-risk NMIBC. He also covers the first results from cohort 4 of SunRISe-1, with a focus on papillary disease-only patients, along

00:00:00

Trial in Progress: Phase 3 MoonRISe-3 Study

CME ·

2025/05/01

00:00:00

Chairperson Perspective: Core Concepts for...

CME ·

2025/04/15

Host: Tycel Phillips, MD Dr. Tycel Phillips presents a summary and offers expert insights on relevant and timely advances in bispecific antibody therapy for the treatment of R/R FL. The activity reviews topics including differentiating approved bispecific antibodies, evidence- and guideline-based treatment planning, patient selection, practical considerations, and optimizing safety in the application of bispecific antibody therapy in R/R FL.

318 results

CME

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事